Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating safety and efficacy of Epi-on corneal cross-linking in progressive keratoconus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Keratoconus

Drugs mentioned

• Epi-on corneal cross-linking (corneal cross-linking (Epi-on))

Snippet

Sponsor: Glaukos Corporation | Conditions: Progressive Keratoconus | Phase 3 | Status: COMPLETED | Results posted: 2024-01-30